Disturbed function of TBL1X has a differential effect on T3-regulated gene expression in two human liver cell models
European Thyroid Journal · 2024
DOI: 10.1530/etj-24-0162 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Thyroid Journal, 2024. Verfasst von Yalan Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Laboratory, Department of Laboratory Medicine, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Transducin, Hepatocytes. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Background
Mutations in TBL1X , part of the NCOR1/SMRT corepressor complex, were identified in patients with hereditary X-linked central congenital hypothyroidism and associated hearing loss. The role of TBL1X in thyroid hormone (TH) action, however, is incompletely understood. The aim of the present study was to investigate the role of TBL1X on T3-regulated gene expression in two human liver cell models.
Methods
A human hepatoma cell line (HepG2) wherein TBL1X was downregulated using siRNAs, and human-induced pluripotent stem cell-derived hepatocytes (iHeps) generated from individuals with a TBL1X N365Y mutation. Both cell types were treated with increasing concentrations of T3. The expression of T3-regulated genes was measured by qPCR.
Results
KLF9 , CPT1A, and PCK1 mRNA expression were higher upon T3 stimulation in the HepG2 cells with decreased TBL1X expression compared to controls, while DIO1 mRNA expression was lower. Hemizygous TBL1X N365Y iHeps exhibited decreased expression of CPT1A , G6PC1 , PCK1 , FBP1, and ELOVL2 compared to cells with the heterozygous TBL1X N365Y allele, but KLF9 and HMGCS2 expression was unaltered.
Conclusion
Downregulation of TBL1X in HepG2 cells and the TBL1X N365Y variant in iHeps have differential effects on T3-regulated gene expression. This suggests that TBL1X may play a gene context role in TH action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrine Laboratory, Department of Laboratory Medicine, University of Amsterdam, Amsterdam, the Netherlands.
- Research Institute Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, the Netherlands.
- Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
- Center for Regenerative Medicine (CReM) of Boston University and Boston Medical Center, Boston, Massachusetts, USA.
- Department of Pediatric Endocrinology. Emma children's hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Department of Endocrinology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
ORCID-Profile: Yalan Hu, Eveline Bruinstroop
Förderung
- NIDDK NIH HHS
Zitieren
APA
Hu, Y., Soares De Oliveira, L., Falize, K., Paul van Trotsenburg, A. S., Fliers, E., Kaserman, J. E., Wilson, A. A., Hollenberg, A. N., Bruinstroop, E., & Boelen, A. (2024). Disturbed function of TBL1X has a differential effect on T3-regulated gene expression in two human liver cell models. European Thyroid Journal. https://doi.org/10.1530/etj-24-0162
Vancouver
Hu Y, Soares De Oliveira L, Falize K, Paul van Trotsenburg AS, Fliers E, Kaserman JE, et al. Disturbed function of TBL1X has a differential effect on T3-regulated gene expression in two human liver cell models. European Thyroid Journal. 2024. doi:10.1530/etj-24-0162
BibTeX
@article{Hu2024,
author = {Hu, Yalan and Soares De Oliveira, Lorraine and Falize, Kim and Paul van Trotsenburg, A S and Fliers, Eric and Kaserman, Joseph E and Wilson, Andrew A and Hollenberg, Anthony N and Bruinstroop, Eveline and Boelen, Anita},
title = {Disturbed function of TBL1X has a differential effect on T3-regulated gene expression in two human liver cell models},
journal = {European Thyroid Journal},
year = {2024},
doi = {10.1530/etj-24-0162}
}
EUVIMED